NCT02680158View on ClinicalTrials.gov

A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye Syndrome

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Dry Eye SyndromeKeratoconjunctivitis Sicca
Interventions
DEVICE

Oculeve Intranasal

Oculeve device, intranasal (test) application for approximately 3 minutes.

DEVICE

Sham

Sham device (control), intranasal application for approximately 3 minutes.

DEVICE

Oculeve Extranasal

Oculeve device, extranasal (control) application for approximately 3 minutes.

Trial Locations (2)

23502

Virginia Eye Consultants, Norfolk

06708

The Eye Care Group, Waterbury

Sponsors

Lead Sponsor

Oculeve, Inc.
All Listed Sponsors
lead

Oculeve, Inc.

INDUSTRY